All animals’ procedures were approved by the Animal Ethics Committee of West China Hospital, Sichuan University. All methods were performed in accordance with the relevant guidelines and regulations. C57BL/6 male mice, about eight weeks old, weighing 18–22 g, were obtained from the Experimental Animal Center of Sichuan University. All mice were tested with a random blood glucose measured by
Glucose Analyzer (Roche, Shanghai, China) as baseline blood glucose concentration and then randomly assigned to normal mice group or diabetes mice group. Each group had 10 mice. All mice were fasted overnight, and injected intraperitoneally with 150 mg kg
−1 streptozocin (Sigma, St. Louis, MO, USA) dissolved in
citrate buffer (pH 4.5, Sigma, St. Louis, MO,USA) or with an equal volume of
citrate buffer. 72 h later, mice with a random blood glucose higher than16.7 mM were defined as diabetic mice
35 (link)–37 . Then mice were feed 8 weeks after injection. Glucose levels were monitored weekly and mice did not meet this criterion were excluded.
Chen Y., Liu G., He F., Zhang L., Yang K., Yu H., Zhou J, & Gan H. (2018). MicroRNA 375 modulates hyperglycemia-induced enteric glial cell apoptosis and Diabetes-induced gastrointestinal dysfunction by targeting Pdk1 and repressing PI3K/Akt pathway. Scientific Reports, 8, 12681.